Skip to content
10-Q

Quarterly Report

Acurx Pharmaceuticals, Inc. ACXP

0001104659-25-109698

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 2.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.28M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 818.17K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 795.39K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.6M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$8.13M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.64M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.57M
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.31M
Stockholders Equity Q3 2025 · Dec 31, 2024 $615.12K
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.66M
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.43M
Stockholders Equity Q3 2025 · Mar 31, 2024 $6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $4.67M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.47M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.24M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.47M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.24M
Total Assets Q3 2025 · Sep 30, 2025 $6.11M
Total Assets Q3 2025 · Dec 31, 2024 $3.86M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.23
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.01
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$3.45
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$14.23
Eps Basic Q3 2025 · Sep 30, 2025 −$1.23
Eps Basic Q3 2025 · Sep 30, 2025 −$5.01
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3.45
Eps Basic restated Q3 2025 · Sep 30, 2024 −$14.23
Rd Expense Q3 2025 · Sep 30, 2025 $429.69K
Rd Expense Q3 2025 · Sep 30, 2025 $1.55M
Rd Expense Q3 2025 · Sep 30, 2024 $1.2M
Rd Expense Q3 2025 · Sep 30, 2024 $4.58M
Net Income Q3 2025 · Sep 30, 2025 −$1.99M
Net Income Q3 2025 · Sep 30, 2025 −$6.39M
Net Income Q3 2025 · Jun 30, 2025 −$2.25M
Net Income Q3 2025 · Mar 31, 2025 −$2.15M
Net Income Q3 2025 · Sep 30, 2024 −$2.82M
Net Income Q3 2025 · Sep 30, 2024 −$11.32M
Net Income Q3 2025 · Jun 30, 2024 −$4.12M
Net Income Q3 2025 · Mar 31, 2024 −$4.38M
Operating Income Q3 2025 · Sep 30, 2025 −$2.03M
Operating Income Q3 2025 · Sep 30, 2025 −$6.47M
Operating Income Q3 2025 · Sep 30, 2024 −$2.83M
Operating Income Q3 2025 · Sep 30, 2024 −$11.33M